11,402 Shares in JPMorgan Chase & Co. $JPM Purchased by Davidson Capital Management Inc.

Key Points

• Davidson Capital Management bought a new stake of 11,402 shares in JPMorgan Chase & Co. (NYSE:JPM) during Q3, valued at about $3.6 million.
• Institutional investors own 71.55% of JPM, with large recent moves including Norges Bank adding a new stake (~$10.3 billion) and several funds (Laurel Wealth, Viking Global, KBC, Mawer) markedly increasing positions.
• Insiders sold a total of 71,596 shares (~$22.1 million) in the past three months (insiders now own 0.47%); analysts have a "Moderate Buy" consensus with an average price target near $340, and JPM recently beat quarterly EPS estimates ($5.23 vs. $4.93).

Davidson Capital Management Inc. bought a new stake in JPMorgan Chase & Co. (NYSE:JPM) during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 11,402 shares of the financial services provider's stock, valued at approximately $3,597,000.

Several other institutional investors have also recently bought and sold shares of JPM. Norges Bank bought a new stake in shares of JPMorgan Chase & Co. in the second quarter worth $10,295,209,000. Laurel Wealth Advisors LLC grew its position in JPMorgan Chase & Co. by 28,813.7% in the second quarter. Laurel Wealth Advisors LLC now owns 16,785,584 shares of the financial services provider's stock valued at $4,866,309,000 after purchasing an additional 16,727,530 shares in the last quarter. Viking Global Investors LP increased its stake in JPMorgan Chase & Co. by 86.1% in the 2nd quarter. Viking Global Investors LP now owns 4,042,034 shares of the financial services provider's stock valued at $1,171,826,000 after buying an additional 1,870,386 shares during the last quarter. KBC Group NV increased its stake in JPMorgan Chase & Co. by 56.3% in the 2nd quarter. KBC Group NV now owns 2,566,562 shares of the financial services provider's stock valued at $744,072,000 after buying an additional 924,915 shares during the last quarter. Finally, Mawer Investment Management Ltd. lifted its position in JPMorgan Chase & Co. by 187.5% during the 2nd quarter. Mawer Investment Management Ltd. now owns 1,241,969 shares of the financial services provider's stock worth $360,059,000 after buying an additional 809,976 shares in the last quarter. Institutional investors own 71.55% of the company's stock.

Insider Activity at JPMorgan Chase & Co.

In related news, insider Robin Leopold sold 432 shares of the business's stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $307.14, for a total transaction of $132,684.48. Following the transaction, the insider directly owned 65,353 shares of the company's stock, valued at approximately $20,072,520.42. The trade was a 0.66% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Jennifer Piepszak sold 8,571 shares of JPMorgan Chase & Co. stock in a transaction on Friday, January 16th. The stock was sold at an average price of $312.79, for a total transaction of $2,680,923.09. Following the transaction, the chief operating officer directly owned 71,027 shares of the company's stock, valued at approximately $22,216,535.33. This trade represents a 10.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 71,596 shares of company stock worth $22,067,932 in the last three months. 0.47% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities analysts have recently commented on JPM shares. DZ Bank restated a "neutral" rating on shares of JPMorgan Chase & Co. in a research note on Wednesday, January 14th. HSBC set a $319.00 target price on JPMorgan Chase & Co. and gave the stock a "hold" rating in a report on Thursday, February 5th. Wall Street Zen raised JPMorgan Chase & Co. from a "sell" rating to a "hold" rating in a research report on Sunday, January 18th. Piper Sandler raised their price target on JPMorgan Chase & Co. from $336.00 to $345.00 and gave the company an "overweight" rating in a research note on Wednesday, January 14th. Finally, CICC Research started coverage on JPMorgan Chase & Co. in a research report on Wednesday, January 14th. They set an "outperform" rating and a $355.00 price target on the stock. Fourteen research analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $340.00.

JPMorgan Chase & Co. News Summary

Here are the key news stories impacting JPMorgan Chase & Co. this week:

• Positive Sentiment: JPMorgan highlighted renewed momentum in biopharma and expects M&A to pick up in 2026, which could support advisory fees and trading revenue in healthcare. 10 Most Shorted Biotech Stocks to Buy According to Hedge Funds
• Positive Sentiment: JPMorgan is a partner in a $100M multi‑company initiative (with Google and others) to cut superpollutants — positive from an ESG and client‑relationship perspective for investment banking and asset management positioning. Google, JPMorgan, Others Launch $100 Million Initiative To Tackle Superpollutants
• Neutral Sentiment: JPMorgan (and affiliates) filed notice that it ceased to be a substantial holder in IDP Education — a portfolio/positioning update that has limited direct impact on the bank itself. JPMorgan Ceases to Be Substantial Holder in IDP Education
• Neutral Sentiment: JPMorgan research published an energy analysis on Germany’s nuclear policy costs — reinforces the bank’s research franchise (supportive for client advisory and institutional credibility but not an immediate earnings driver). The cost of Germany’s long and painful nuclear regret
• Negative Sentiment: A federal judge ruled employees may pursue claims that JPMorgan mismanaged its health/prescription benefits, alleging overpayment for drugs/premiums — potential litigation exposure, reputational risk and possible plan changes that could carry costs or reserve requirements. JPMorgan Chase employees may sue over high drug costs and premiums, judge rules
• Negative Sentiment: JPMorgan strategists warned the Iran war could drive a ~10% S&P 500 drop — a signal of heightened macro risk that may reduce trading volumes, M&A activity and investment banking fees if volatility persists. JP Morgan forecasts 10% plunge in S&P 500 over Iran war
• Negative Sentiment: Senior JPM executives and strategists (including Jake Manoukian, Mislav Matejka and CEO commentary) cautioned about “too much exuberance,” inflation risks and that markets “might need to get worse before they can get better,” which could damp investor risk appetite and near‑term fee pools. When it comes to the war in Iran don’t go betting on the TACO trade, says top J.P. Morgan investment strategist JPMorgan CEO: "Too Much Exuberance" in Stocks -- Should Investors Beware? JPM’s Matejka warns ’things might need to get worse before they can get better’

JPMorgan Chase & Co. Stock Up 0.2%

Shares of JPM stock opened at $290.04 on Tuesday. JPMorgan Chase & Co. has a 52-week low of $202.16 and a 52-week high of $337.25. The stock has a market cap of $782.24 billion, a price-to-earnings ratio of 14.49, a PEG ratio of 1.20 and a beta of 1.06. The firm's 50-day moving average is $309.75 and its 200-day moving average is $308.76. The company has a debt-to-equity ratio of 1.27, a quick ratio of 0.85 and a current ratio of 0.85.

JPMorgan Chase & Co. (NYSE:JPM - Get Free Report) last posted its quarterly earnings results on Tuesday, January 13th. The financial services provider reported $5.23 EPS for the quarter, topping analysts' consensus estimates of $4.93 by $0.30. The business had revenue of $45.80 billion during the quarter, compared to analysts' expectations of $45.98 billion. JPMorgan Chase & Co. had a return on equity of 17.16% and a net margin of 20.35%.JPMorgan Chase & Co.'s quarterly revenue was up 7.1% on a year-over-year basis. During the same quarter last year, the company posted $4.81 earnings per share. Sell-side analysts predict that JPMorgan Chase & Co. will post 18.1 EPS for the current year.

JPMorgan Chase & Co. Profile

JPMorgan Chase & Co NYSE: JPM is a diversified global financial services firm headquartered in New York City. The company provides a wide range of banking and financial products and services to consumers, small businesses, corporations, governments and institutional investors worldwide. Its operations span retail banking, commercial lending, investment banking, asset management, payments and card services, and treasury and securities services.

The firm's principal business activities are organized across several core lines: Consumer & Community Banking, which offers deposit accounts, mortgages, auto loans, credit cards and branch and digital banking under the Chase brand; Corporate & Investment Banking, which provides capital markets, advisory, underwriting, trading and risk management services; Commercial Banking, delivering lending, treasury and capital solutions to middle-market and corporate clients; and Asset & Wealth Management, which offers investment management, private banking and retirement services to institutions and high-net-worth individuals.

Want to see what other hedge funds are holding JPM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for JPMorgan Chase & Co. (NYSE:JPM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.